Mercer Global Advisors
TARA icon

Mercer Global Advisors’s Protara Therapeutics TARA Stock Holding History

Mercer Global Advisors’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5K Buy
+9,038
New +$43K ﹤0.01% 4527

Other funds holding TARA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Mercer Global Advisors's TARA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Protara Therapeutics (TARA) in Q2 2026: 9,038 shares worth $34.5K. The stake represents ﹤0.01% of the portfolio and ranks #4527 among its holdings.

99 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Mercer Global Advisors held 9,038 shares of Protara Therapeutics worth $34.5K as of Q2 2026.
  • Protara Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Protara Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4527 holding.
  • 99 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.